The launch coincides with the development of a 15,000 square foot CRO facility in Lancashire, U.K., designed specifically to address the needs of the electronic nicotine delivery systems (ENDS) market. Having operated in this rapidly expanding and changing market for almost 10 years, the company believes it is now perfectly placed to guide ENDS companies through a period of growth and regulatory change.
Broughton Nicotine Services raised more than £5 million ($6.58 million) in 2018 to invest in the new facility, which includes several specialist laboratories equipped with the latest aerosol collection instruments, high-spec analytical equipment and fully validated software data management systems.
A standalone stability facility covering all ICH storage requirements has been included in this initial phase of developments. Led by a growing team of experienced scientists and analytical chemists, the operation is aligned with capacity for further expansion during 2019 to meet the expectations of its global client base.
‘’We have seen rapid change over recent years within the reduced-risk nicotine products market,” says Broughton Nicotine Services CEO Paul Moran. “At Broughton Nicotine Services, we are committed to supporting this evolving industry towards creating a smoke-free future through innovations, scientific advancement and regulatory compliance. Operating as an independent company within the Broughton Group, specializing in next generation nicotine delivery, will enable us to continue to accelerate the transformation of this exciting industry for our clients.”